BillionToOne, Inc. (BLLN) News
Follow BillionToOne, Inc. (BLLN) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 15 public stories across 12 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
BillionToOne Reports Third-Quarter Results, Raises 2026 Revenue Guidance
EQUITY | Nov 04, 2026, 09:08 PM UTC
M
BillionToOne to report third-quarter 2026 results November 4
EQUITY | Oct 14, 2026, 12:05 PM UTC
L
Weekly Recap: Northstar reimbursement +29% and CMS 15% lab fee cuts
BillionToOne, Inc. Class A (NASDAQ:BLLN) saw Northstar Response test reimbursement jump 29% to $2,124, but looming MolDx coverage decisions and CMS’s phased lab fee cuts—capped at about 15% annually through 2029—could pr
NEWS | Sep 28, 2026, 11:03 AM UTC
M
BLLN Q2 revenue rises 64% with strong margins and oncology growth
BLLN reported 64% Q2 revenue growth and strong profitability, driven by gains in prenatal and oncology. The company said independent clinics drive most growth, while health system integration investments and new products
EQUITY | Sep 09, 2026, 07:08 PM UTC
L
BLLN - BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference
BLLN - BillionToOne to Participate in the Wells Fargo 21st Annual Healthcare Conference
EQUITY | Sep 02, 2026, 08:06 PM UTC
L
BillionToOne initiated at Buy by Canaccord Genuity
Canaccord Genuity initiated coverage of BillionToOne at Buy.
EQUITY | Sep 02, 2026, 03:52 PM UTC
L
BillionToOne launches Northstar Origin liquid biopsy test
BillionToOne launches Northstar Origin, a new liquid biopsy test to help identify tissue of origin.
EQUITY | Sep 01, 2026, 01:01 PM UTC
L
BillionToOne launches Northstar Origin liquid biopsy add-on test
BillionToOne introduced Northstar Origin, an add-on test using a single blood draw, to help identify tissue of origin. It also expanded the Northstar Select panel to 102 genes.
EQUITY | Sep 01, 2026, 01:00 PM UTC
L
BLLN - /C O R R E C T I O N -- BillionToOne/
BLLN - /C O R R E C T I O N -- BillionToOne/
EQUITY | Aug 19, 2026, 02:22 PM UTC
L
BLLN - Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Re
BLLN - Largest Prospective Study in General-Risk Pregnancies Strengthens Evidence for cfDNA Fetal Risk Assessment as a Primary Screen for Recessive Conditions
EQUITY | Aug 18, 2026, 04:10 PM UTC
L
BillionToOne Stock (BLLN) Falls After Hours: Here's What's Driving the Move
BillionToOne, Inc. (NASDAQ: BLLN ) shares fell 28.12% in Wednesday’s after-hours session after the company reported its second-quarter financial results. The stock closed Wednesday’s regular session up 5.43% at $149.97 b
EARNINGS | Aug 06, 2026, 06:01 AM UTC
L
BillionToOne Affirms FY2026 Sales Guidance of $450.000M-$465.000M vs $456.440M Est
BillionToOne (NASDAQ: BLLN ) affirms FY2026 sales outlook from $450.000 million-$465.000 million to $450.000 million-$465.000 million vs $456.440 million estimate.
EARNINGS | Aug 05, 2026, 08:14 PM UTC
L
BLLN - BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance
BLLN - BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance
EARNINGS | Aug 05, 2026, 08:06 PM UTC
L
Billiontoone Insider Sold Shares Worth $533,330, According to a Recent SEC Filing
() -- John Roderick ten Bosch, Senior Vice President, Laboratory Operations, on July 13, 2026, sold 4,251 shares in Billiontoone (BLLN) for $533,330. Following the Form 4 filing with the SEC, ten Bosch has control over a
GEOPOLITICS | Jul 15, 2026, 08:48 PM UTC
L
Billiontoone Insider Sold Shares Worth $1,576,276, According to a Recent SEC Filing
() -- Oguzhan Atay, Director, Chairman, and CEO, on July 09, 2026, sold 12,500 shares in Billiontoone (BLLN) for $1,576,276. SEC Filing: Copyright © 2026. All rights reserved. does not provide investment advice. Unauthor
REGULATION | Jul 13, 2026, 08:41 PM UTC